The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030
Abstract
OBJECTIVE: Despite the importance of diabetes for global health, the future economic consequences of the disease remain opaque. We forecast the full global costs of diabetes in adults through the year 2030 and predict the economic consequences of diabetes if global targets under the Sustainable Development Goals (SDG) and World Health Organization Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020 are met. RESEARCH DESIGN AND METHODS: We modeled the absolute and gross domestic product (GDP)-relative economic burden of diabetes in individuals aged 20–79 years using epidemiological and demographic data, as well as recent GDP forecasts for 180 countries. We assumed three scenarios: prevalence and mortality 1) increased only with urbanization and population aging (baseline scenario), 2) increased in line with previous trends (past trends scenario), and 3) achieved global targets (target scenario). RESULTS: The absolute global economic burden will increase from U.S. $1.3 trillion (95% CI 1.3–1.4) in 2015 to $2.2 trillion (2.2–2.3) in the baseline, $2.5 trillion (2.4–2.6) in the past trends, and $2.1 trillion (2.1–2.2) in the target scenarios by 2030. This translates to an increase in costs as a share of global GDP from 1.8% (1.7–1.9) in 2015 to a maximum of 2.2% (2.1–2.2). CONCLUSIONS: The global costs of diabetes and its consequences are large and will substantially increase by 2030. Even if countries meet international targets, the global economic burden will not decrease. Policy makers need to take urgent action to prepare health and social security systems to mitigate the effects of diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040
Ogurtsova, K., da Rocha Fernandes, J. D., Huang, Y., Linnenkamp, U., Guariguata, L., Cho, N. H., Cavan, D., Shaw, J. E., & Makaroff, L. E. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.03.024 · Cited by 6,966
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citationZhou, B., Lu, Y., Hajifathalian, K., Bentham, J., Di Cesare, M., Danaei, G., Bixby, H., Cowan, M., Ali, M., Taddei, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00618-8 · Cited by 4,311
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147
Economic Costs of Diabetes in the U.S. in 2012
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc12-2625 · Cited by 2,163
(2012) · RePEc: Research Papers in Economics · Cited by 1,951
Global healthcare expenditure on diabetes for 2010 and 2030
Zhang, P., Zhang, X., Brown, J., Vistisen, D., Sicree, R., Shaw, J., & Nichols, G. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.01.026 · Cited by 1,145
Hex, N., Bartlett, C., Wright, D., Taylor, M., & Varley, D. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03698.x · Cited by 819
The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study
Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Bärnighausen, T., & Vollmer, S. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30097-9 · Cited by 816
Self-citation
Cited by
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association
Benjamin, E. J., Muntner, P., Alonso, A., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Das, S. R., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000659 · Cited by 9,036
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
Williams, R., Karuranga, S., Malanda, B., Saeedi, P., Basit, A., Besançon, S., Bommer, C., Esteghamati, A., Ogurtsova, K., Zhang, P., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108072 · Cited by 861
Self-citationThe Lancet Commission on diabetes: using data to transform diabetes care and patient lives
Chan, J. C. N., Lim, L.-L., Wareham, N. J., Shaw, J. E., Orchard, T. J., Zhang, P., Lau, E. S. H., Eliasson, B., Kong, A. P. S., Ezzati, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32374-6 · Cited by 793
The global epidemics of diabetes in the 21st century: Current situation and perspectives
Standl, E., Khunti, K., Hansen, T. B., & Schnell, O. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319881021 · Cited by 497
Papachristoforou, E., Lambadiari, V., Maratou, E., & Makrilakis, K. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7489795 · Cited by 479
Mishra, M., Desul, S., Santos, C. A. G., Mishra, S. K., Kamal, A. H. M., Goswami, S., Kalumba, A. M., Biswal, R., da Silva, R. M., dos Santos, C. A. C., et al. (2023) · Environment, Development and Sustainability · doi:10.1007/s10668-023-03225-w · Cited by 317
Han, H., Cao, Y., Feng, C., Zheng, Y., Dhana, K., Zhu, S., Shang, C., Yuan, C., & Zong, G. (2022) · Diabetes Care · doi:10.2337/dc21-1512 · Cited by 290
Gut microbiota influence in type 2 diabetes mellitus (T2DM)
Cunningham, A. L., Stephens, J. W., & Harris, D. A. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00446-0 · Cited by 270
Diabetes, heart failure, and renal dysfunction: The vicious circles
Braunwald, E. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.07.003 · Cited by 254
Altered mitochondrial function in insulin-deficient and insulin-resistant states
Ruegsegger, G. N., Creo, A. L., Cortes, T. M., Dasari, S., & Nair, K. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120843 · Cited by 202
The cost of diabetes care-an elephant in the room
Riddle, M. C., & Herman, W. H. (2018) · Diabetes Care · doi:10.2337/dci18-0012 · Cited by 191
Beyond the CNS: The many peripheral roles of APOE
Martínez-Martínez, A. B., Torres-Perez, E., Devanney, N., Del Moral, R., Johnson, L. A., & Arbones-Mainar, J. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104809 · Cited by 149
Continuous glucose monitoring for the routine care of type 2 diabetes mellitus
Ajjan, R. A., Battelino, T., Cos, X., Del Prato, S., Philips, J.-C., Meyer, L., Seufert, J., & Seidu, S. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00973-1 · Cited by 117
“164).”
Mirahmadizadeh, A., Khorshidsavar, H., Seif, M., & Sharifi, M. H. (2020) · Diabetes Therapy · doi:10.1007/s13300-019-00750-8 · Cited by 111
The role of structural racism and geographical inequity in diabetes outcomes
Agarwal, S., Wade, A. N., Mbanya, J. C., Yajnik, C., Thomas, N., Egede, L. E., Campbell, J. A., Walker, R. J., Maple-Brown, L., & Graham, S. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00909-1 · Cited by 97
Basu, S., Wagner, R. G., Sewpaul, R., Reddy, P., & Davies, J. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30450-9 · Cited by 69
Self-citationAltobelli, E., Angeletti, P. M., Marziliano, C., Mastrodomenico, M., Giuliani, A. R., & Petrocelli, R. (2021) · Nutrients · doi:10.3390/nu13020404 · Cited by 67
Ni, C., Jia, Q., Ding, G., Wu, X., & Yang, M. (2022) · Nutrients · doi:10.3390/nu14020307 · Cited by 56
Ballin, M., Nordström, P., Niklasson, J., Alamäki, A., Condell, J., Tedesco, S., & Nordström, A. (2020) · BMC Public Health · doi:10.1186/s12889-020-09929-2 · Cited by 47
Enricho Nkhoma, D., Jenya Soko, C., Joseph Banda, K., Greenfield, D., Li, Y.-C. (., & Iqbal, U. (2021) · BMJ Health & Care Informatics · doi:10.1136/bmjhci-2020-100291 · Cited by 46
Lechner, K., Lechner, B., Crispin, A., Schwarz, P. E. H., & von Bibra, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-87266-z · Cited by 46
Mechanisms of aerobic exercise impairment in diabetes: a narrative review
Wahl, M. P., Scalzo, R. L., Regensteiner, J. G., & Reusch, J. E. B. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00181 · Cited by 44
Ruissen, M. M., Torres-Peña, J. D., Uitbeijerse, B. S., Arenas de Larriva, A. P., Huisman, S. D., Namli, T., Salzsieder, E., Vogt, L., Ploessnig, M., van der Putte, B., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-06006-2 · Cited by 43
Zhang, L., Shang, X., Sreedharan, S., Yan, X., Liu, J., Keel, S., Wu, J., Peng, W., & He, M. (2020) · JMIR Medical Informatics · doi:10.2196/16850 · Cited by 40
Chu, H., Chen, L., Yang, X., Qiu, X., Qiao, Z., Song, X., Zhao, E., Zhou, J., Zhang, W., Mehmood, A., et al. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.645418 · Cited by 40
Yoshida, Y., Cheng, X., Shao, H., Fonseca, V. A., & Shi, L. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1292-5 · Cited by 39
Siopis, G., Colagiuri, S., & Allman-Farinelli, M. (2021) · Journal of Nutrition Education and Behavior · doi:10.1016/j.jneb.2020.09.003 · Cited by 37
Liu, C., De Roza, J., Ooi, C. W., Mathew, B. K., Elya, & Tang, W. E. (2022) · BMC Primary Care · doi:10.1186/s12875-022-01627-9 · Cited by 33
Boonpor, J., Parra-Soto, S., Petermann-Rocha, F., Lynskey, N., Cabanas-Sánchez, V., Sattar, N., Gill, J. M. R., Welsh, P., Pell, J. P., Gray, S. R., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-02851-5 · Cited by 31
Shi, F.-H., Li, H., Shen, L., Zhang, Z., Jiang, Y.-H., Hu, Y.-M., Liu, X.-Y., Gu, Z.-C., Ma, J., & Lin, H.-W. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01066 · Cited by 30
“The prevalence of T2DM is rapidly increasing especially in developing countries (King et al., 1998; Bommer et al., 2018).”
BackgroundTarricone, R., Petracca, F., Svae, L., Cucciniello, M., & Ciani, O. (2024) · eBioMedicine · doi:10.1016/j.ebiom.2024.105091 · Cited by 26
Niu, X.-D., Chi, J.-T., Guo, J.-B., Ruan, H.-H., Zhang, J., Tao, H.-X., & Wang, Y.-H. (2021) · Journal of Telemedicine and Telecare · doi:10.1177/1357633x211010019 · Cited by 19
Beltran-Valls, M. R., Cabanas-Sánchez, V., Sadarangani, K. P., Rodríguez-Artalejo, F., Moliner-Urdiales, D., & Martínez-Gómez, D. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101410 · Cited by 21
Toffolutti, V., Stuckler, D., McKee, M., Wolsey, I., Chapman, J., J Pimm, T., Ryder, J., Salt, H., & M Clark, D. (2021) · Journal of Health Services Research & Policy · doi:10.1177/1355819621997493 · Cited by 16
The Impact of Nutritional Interventions on Child Health and Cognitive Development
Bommer, C., Mittal, N., & Vollmer, S. (2020) · Annual Review of Resource Economics · doi:10.1146/annurev-resource-110519-093256 · Cited by 12
Self-citationBoucher, E., Moskowitz, J. T., Kackloudis, G. M., Stafford, J. L., Kwok, I., & Parks, A. C. (2020) · JMIR Research Protocols · doi:10.2196/18578 · Cited by 6
The pursuit of optimal semaglutide dosing in type 2 diabetes continues
Sherrill, C. H., & Hwang, A. Y. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01233-3 · Cited by 5
Does the encounter type matter when defining diabetes complications in electronic health records?
Hong, D., Shen, Y., Monnette, A., Liu, S., Shao, H., Nauman, E., Price-Haywood, E., Hu, G., & Shi, L. (2020) · Medical Care · doi:10.1097/mlr.0000000000001297 · Cited by 4
Ratzki-Leewing, A., Harris, S. B., Rabasa-Lhoret, R., & Poon, Y. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0609 · Cited by 3
Metadata
- Authors
- Bommer, C., Sagalova, V., Heesemann, E., Manne-Goehler, J., Atun, R., Bärnighausen, T., Davies, J., & Vollmer, S.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-02-23
- Volume
- 41
- Issue
- 5
- Pages
- 963-970
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2791113526
- Cited by
- 1,130
- References
- 24
- FWCI
- 145.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.